1. Home
  2. BATRK vs RLAY Comparison

BATRK vs RLAY Comparison

Compare BATRK & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series C

BATRK

Atlanta Braves Holdings Inc. Series C

HOLD

Current Price

$51.89

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$18.14

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BATRK
RLAY
Founded
1991
2015
Country
United States
United States
Employees
1610
N/A
Industry
Broadcasting
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BATRK
RLAY
Price
$51.89
$18.14
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$60.00
$19.50
AVG Volume (30 Days)
483.6K
3.6M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.78
EPS
N/A
N/A
Revenue
N/A
$15,355,000.00
Revenue This Year
$12.40
N/A
Revenue Next Year
$8.54
$324.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.44
52 Week Low
$37.76
$3.03
52 Week High
$52.11
$17.70

Technical Indicators

Market Signals
Indicator
BATRK
RLAY
Relative Strength Index (RSI) 62.40 74.33
Support Level $48.46 $6.67
Resistance Level $52.05 N/A
Average True Range (ATR) 1.24 0.96
MACD 0.09 0.37
Stochastic Oscillator 81.90 88.31

Price Performance

Historical Comparison
BATRK
RLAY

About BATRK Atlanta Braves Holdings Inc. Series C

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: